Table 2.
Other parameters.
| Study ID | Outcomes | P Value |
|---|---|---|
| Hatice Dilek Doğan 2021 | Multiple sclerosis quality of life-54 (MSQOL-54) scale | <.001 |
| Mahbobeh Sajadi 2020 | Constipation assessment scale (CAS) | .0001 |
| Stool frequency | .0001 | |
| Mahbobeh Sajadi 2020 | Fatigue impact scale (FIS) | .134 |
| Pittsburgh sleep quality index (PSQI) | .001 | |
| State-trait anxiety inventory (STAI) | .034 | |
| Nusrat Ebrahimi 2020 | Stress symptom index (SSI) | <.00001 |
| Serum ortisol levels | <.00001 | |
| Mozhgan Soheili 2022 | Anxiety score | .04 |
| Stress score | .004 | |
| Depression score [depression anxiety and stress scale-21 (DASS.21)] | .01 | |
| Peter A. Mackereth 2009 | General health questionnaire 28 (GHQ28)- severe depression | .2485 |
| GHQ28 – somatic symptoms | .9738 | |
| GHQ28 – anxiety and insomnia | .7923 | |
| GHQ28 – social dysfunction | .6809 | |
| State anxiety inventory (SAI) – state anxiety | .4378 | |
| SAI – Cortisol | .8699 | |
| SAI – systolic pressure | .9935 | |
| SAI – diastolic pressure | .6847 | |
| SAI – heart rate | .6985 | |
| L Miller 2013 | Multiple sclerosis impact scale (MSIS29) | .538 |
| Hospital anxiety and depression scale (HAD) | – | |
| HAD anxiety | .679 | |
| HAD depression | .8113 | |
| Fatemeh Nazari 2015 | Numeric rating scale (NRS) pain score | <.001 |
| I Siev-Ner 2003 | Urinary symptoms [American urological association (AUA) symptom score] | .03 |
| Spastisity, muscle tone-by Ashworth score | .03 | |
| Muscle strength-by British medical research council (BMRC) scale | .06 |
CAS = problem assessment scale, FIS = fatigue impact scale, HAD = hospital anxiety and depression scale, MSIS29 = multiple sclerosis impact scale, MSQOL-54 = multiple sclerosis quality of life-54, NRS = numeric rating scale, SAI = state anxiety inventory, SSI = stress symptom index.